Recombinant Proteins and Monoclonal Antibodies as Drugs, Molecular Biology, Biochemistry, Genes, Clone, Monoclonal Antibodies

Scholarships Dictionary Visa Details Study Abroad Exam Results Online Test Jobs

	Home
Drug Discovery and Drug Designing Drug Discovery and Drug Designing Introduction Early History of Drug Discovery History of Drug Discovery Enzymes/Receptors as Drug Targets Receptors as Drug Targets Enzymes as Drug Targets Molecular Biology for Drug Discovery Recombinant Proteins and Monoclonal Antibodies as Drugs Molecular basis of Disease Processes Target Identification and Validation Combinatorial Chemistry and HTS Organic Synthesis (Combinatorial Chemistry for Drug Discovery) Target-Oriented Organic Synthesis and Retrosynthetic Analysis

Home >> Industrial and Microbial Biotechnology >>Drug Discovery and Drug Designing >> Recombinant Proteins and Monoclonal Antibodies as Drugs

Your Ad Here

Recombinant Proteins and Monoclonal Antibodies as Drugs

Molecular biology exerted a profound influence on drug discovery, through the use of genetic information translated in the language of biochemistry and chemistry. One of the major uses of molecular biology in drug development is cloning and expressing genes that encode therapeutically useful proteins. The total number of such 'biotech' drugs, including recombinant proteins and monoclonal antibodies were, however, only -60 in the year 2000. In the year 1998 alone, out of 57 drugs that were introduced worldwide, 15 (26.3%) were either recombinant proteins or monoclonal antibodies. Besides recombinant insulin and interferons, several other recombinant proteins that are or will be used as drugs include the following: tissue plasminogen activator (tPA), erythro-poietin, granulocute-macrophage colony-stimulating factor, Herceptin, rituximat, etc

	Home
Diversity-Oriented Organic Synthesis and Evolving Synthetic Analysis Solid Phase Synthesis for Drug Discovery Combinatorial Biocatalysis for Drug Disovery Synthesis of Bergenin Derivatives Drug Discovery in Cancer Research Microbial Genomics for New Antibiotics Genomics Drugs (Pharmacogenomics) Immunotoxins as Drugs Drug Designing Drug Designing by Blocking Enzyme Activity Drug Designing through Blocking Hormone Receptors Drug Designing through Inhibition of Nucleic Acid Synthesis Drug Designing Against Heterogeneous Targets